Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Express Scripts
Queensland Health
Baxter
Deloitte
Merck
Teva
Medtronic

Generated: April 20, 2018

DrugPatentWatch Database Preview

BENOXINATE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Benoxinate Hydrochloride patents expire, and when can generic versions of Benoxinate Hydrochloride launch?

Benoxinate Hydrochloride is a drug marketed by Sola Barnes Hind and is included in one NDA.

The generic ingredient in BENOXINATE HYDROCHLORIDE is benoxinate hydrochloride. There is one drug master file entry for this compound. Additional details are available on the benoxinate hydrochloride profile page.
Drug patent expirations by year for BENOXINATE HYDROCHLORIDE
Synonyms for BENOXINATE HYDROCHLORIDE
[2-(4-AMINO-3-BUTOXYBENZOYLOXY)ETHYL]DIETHYLAZANIUM CHLORIDE
099A434
0VE4U49K15
13718-13-3
13718-13-3 (hydrochloride)
2-(4-amino-3-butoxy-benzoyl)oxyethyl-diethyl-ammonium chloride
2-(4-amino-3-butoxybenzoyl)oxyethyl-diethylazanium chloride
2-(4-azanyl-3-butoxy-phenyl)carbonyloxyethyl-diethyl-azanium chloride
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate (HCl)
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate HCl
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate hydrochloride
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate hydrochloride; Benoxinate hydrochloride
2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate monohydrochloride
2-(diethylamino)ethyl 4-amino-3-butoxybenzoate, chloride
2-(diethylamino)ethyl 4-amino-3-butoxybenzoate;hydrochloride
2-(diethylamino)ethyl 4-amino-3-n-butoxybenzoate
2-(diethylamino)ethyl 4-azanyl-3-butoxy-benzoate hydrochloride
2-(Diethylamino)ethyl4-amino-3-butoxybenzoatehydrochloride
2-[(4-amino-3-butoxybenzoyl)oxy]-N,N-diethylethanaminium chloride
2-[(4-amino-3-butoxyphenyl)-oxomethoxy]ethyl-diethylammonium chloride
2-Diethylaminoethyl 4-amino-3-butoxybenzoate
2-diethylaminoethyl 4-amino-3-butoxybenzoate hydrochloride
3-Butoxy-4-aminobenzoic acid 2-(diethylamino)ethyl ester
3-Butoxy-4-aminobenzoic acid 2-diethylaminoethyl ester
4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid
4-amino-3-butoxy-2-(diethylamino)ethylester-benzoicacid
4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester
4-amino-3-butoxybenzoic acid 2-(diethylamino)ethyl
4-Amino-3-butoxybenzoic acid 2-(diethylamino)ethyl ester
4-Amino-3-butoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride
4-Amino-3-butoxybenzoic acid 2-diethylaminoethyl ester
4-Amino-3-butoxybenzoic acid diethylaminoethyl ester
4-Amino-3-butoxybenzoicacid 2-diethylaminoethyl ester
4-Amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester
4-Amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester [German]
5987-82-6
5987-82-6 (mono-hydrochloride)
987B826
99-43-4
99-43-4 (Parent)
A832522
A846023
AB0218160
AC1L1ILS
AC1L2K4W
AC1O4WID
ACT03847
AJ-32707
AK116508
AK213230
AKOS005457803
AKOS015890626
AKOS016010466
AKOS026749882
ALBB-025704
API0006915
API0015835
AX8115337
AXQ0JYM303
BBL003343
Benoxil
Benoxil (TN)
Benoxinate
Benoxinate HCL
Benoxinate hydrochlori
Benoxinate hydrochloride (USP)
Benoxinate hydrochloride [USP]
Benoxinate hydrochloride, >=98%
Benoxinate hydrochloride, meets USP testing specifications
Benoxinate hydrochloride, United States Pharmacopeia (USP) Reference Standard
benoxinate monohydrochloride
BENZOIC ACID, 4-AMINO-3-BUTOXY-, 2-(DIETHYLAMINO)ETHYL ESTER
Benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester (7CI,8CI,9CI)
BENZOIC ACID, 4-AMINO-3-BUTOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester, hydrochloride (1:1)
BENZOIC ACID, 4-AMINO-3-BUTOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE
BPBio1_000235
BRD-K04185004-003-03-6
BRN 2288926
BSPBio_000213
Butoxyaminobenzoyldiethylaminoethanol
butoxyprocaine
C-49533
C17H28N2O3.HCl
CAS-5987-82-6
CCG-213472
Cebesine
CHEBI:309594
CHEBI:31260
CHEMBL1200
CHEMBL1200654
CMHHMUWAYWTMGS-UHFFFAOYSA-N
Conjucain
Conjuncain
D01768
D08319
D0H2SY
DB00892
diethylaminoethyl-4-amino-3-butoxybenzoate
Dorsacain
Dorsacaine
Dorsacaine hydrochloride
DSSTox_CID_25393
DSSTox_GSID_45393
DSSTox_RID_80850
DTXSID4045393
DTXSID7048530
EBD39266
EINECS 227-808-8
Epitope ID:122669
Fluress
FT-0635932
FT-0659855
GTPL7123
HMS1568K15
HMS2235J23
HMS3369H13
HMS3604F05
HYDROGEN OXYBUPROCAINE CHLORIDE
I01-7205
I01-7232
KB-224006
KS-00000FOP
Lacrimin
LS-35639
LS-35642
LS-35643
LT00771788
MCULE-5566120451
MCULE-6163662348
MFCD00012512
MFCD00242863
Minims Benoxinate
Minims Oxybuprocaine
MLS001332643
MLS001332644
MLS002154187
MolPort-003-940-459
MolPort-006-167-653
Monofree oxybuprocaine
Monofree oxybuprocaine (TN)
NCGC00016667-01
NCGC00016667-02
NCGC00016667-04
Novescine
Novesin
Novesin (TN)
Novesina
Novesine
Novesine (TN)
Novesinol
NSC-759847
NSC759847
Opulets Benoxinate
OR024696
OR069132
OR069133
OR292242
OR382724
Oxbarukain
Oxibuprocaina
Oxibuprocaina [INN-Spanish]
OXIBUPROCAINE CHLORIDE
Oxibuprocainum
Oxibuprokain
Oxybucaine
Oxybuprocaine
Oxybuprocaine (INN)
Oxybuprocaine [INN:BAN]
Oxybuprocaine HCL
oxybuprocaine hydrochloride
Oxybuprocaine hydrochloride (JP17)
Oxybuprocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
oxybuprocaine monohydrochloride
Oxybuprocainum
Oxybuprocainum [INN-Latin]
Oxyriprocaine
Pharmakon1600-01505502
Prescaina
Prestwick_896
Prestwick0_000057
Prestwick1_000057
Prestwick2_000057
Prestwick3_000057
R1237
S 749
s4229
SBB065174
SBB065181
SC-81194
SCHEMBL15532182
SCHEMBL212440
SCHEMBL25087
SMR000857098
SMR001233478
SPBio_002134
SR-01000841198
SR-01000841198-3
ST24039629
ST45028778
ST50993908
STK520615
TL8003806
Tox21_110553
Tox21_110553_1
UNII-0VE4U49K15
UNII-AXQ0JYM303
Z3711
ZINC2019492
ZX-AN024218

US Patents and Regulatory Information for BENOXINATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind BENOXINATE HYDROCHLORIDE benoxinate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084149-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Citi
Merck
Fuji
Baxter
Dow
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.